Skip to main content


A double-blind randomized clinical trial on the efficacy of cortical direct current stimulation for the treatment of Alzheimer's disease.

Research Authors
Khedr EM1, Gamal NF1, El-Fetoh NA1, Khalifa H1, Ahmed EM1, Ali AM1, Noaman M1, El-Baki AA1, Karim AA2.
Research Journal
Front Aging Neurosci.
Research Member
Research Publisher
Karger AG, Base
Research Rank
1
Research Vol
6
Research Website
pubmed-index medline
Research Year
2014
Research_Pages
275.
Research Abstract

Abstract
BACKGROUND:
The purpose of this study was to investigate the long-term efficacy of transcranial direct current stimulation (tDCS) in the neurorehabilitation of Alzheimer's disease (AD).
METHODS:
Thirty-four AD patients were randomly assigned to three groups: anodal, cathodal, and sham tDCS. Stimulation was applied over the left dorsolateral prefrontal cortex for 25 min at 2 mA, daily for 10 days. Each patient was submitted to the following psychometric assessments: mini-mental state examination (MMSE) and Wechsler adult intelligence scale-third edition at base line, at the end of the 10th sessions and then at 1 and 2 months after the end of the sessions. Motor cortical excitability and the P300 event-related potential were assessed at baseline and after the last tDCS session.
RESULTS:
Significant treatment group × time interactions were observed for the MMSE and performance IQ of the WAIS. Post hoc comparisons showed that both anodal and cathodal tDCS (ctDCS) improved MMSE in contrast to sham tDCS. Whereas, this was only true for ctDCS in the performance IQ. Remarkably, tDCS also reduced the P300 latency, but had no effect on motor cortex excitability.
CONCLUSION:
Our findings reveal that repeated sessions of tDCS could not only improve cognitive function but also reduce the P300 latency, which is known to be pathologically increased in AD.